Skip to content

Pain and Anxiety During Transrectal Prostate Biopsy

Comparison of the Effects of Music and Tens Application on Patient's Perception on Pain and Anxiety During Transrectal Prostate Biopsy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05358223
Enrollment
150
Registered
2022-05-03
Start date
2022-03-14
Completion date
2023-03-14
Last updated
2022-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Biopsy

Keywords

pain, periprostatic block, transcutaneous electrical stimulation, music

Brief summary

Many studies have been conducted in the literature to manage pain and anxiety levels for patients undergoing transrectal prostate biopsy. In addition to the periprostatic block application recommended in the guidelines of the European Association of Urology, there are studies showing that TENS application or music applications will make an additional contribution.However, there is no study comparing the effect of TENS and music.

Detailed description

Patients who applied to the urology outpatient clinic and whose prostate biopsy decision was made in accordance with the criteria specified in the guidelines of the European urology society will be randomized into 5 groups. group 1: will apply only periprostatic block group 2: patients who will undergo periprostatic block + listen to music group 3 : patients to whom periprostatic block will be applied + tens device will be applied group 4 : patients who will only listen to music group 5 : patients who will only be treated with tens A standard music determined by us for the 1st and 4th groups will be played during the process. TENS device will be connected to the 3rd and 5th groups during the process and the process will be done in this way. In our study, a 2-channel TENS device will be used. One of the electrodes connected to the first channel will be placed in the right anterior suprapubic region and the other in the right posterior presacral area. The electrodes connected to the second channel will be placed in the left anterior suprapubic region and left posterior presacral region, similar to the other. At least 3-6 minutes before the biopsy, stimulation will be started from the lower energy rising to 60 milliamperes with a frequency of 100 Hz and a pulse width of 150 µs. the amplitude will be adjusted individually for each participant to a level they can tolerate. The blood pressure, pulse, respiratory rate and spo2 values of the patients are measured at the beginning, middle and end of the procedure and recorded. In our study, these data will be used by obtaining from the files of the patients. In all groups, at the beginning, middle and end of the prostate biopsy procedure, an evaluation will be made with a visual analog score to evaluate the pain status of the patients. Anxiety levels will be calculated with the state-continuity and anxiety scale that will be given to the patients the day before the procedure in all groups. After the prostate biopsy procedure is completed, this scale will be given to the patients again and their anxiety status will be re-evaluated after the procedure. All the obtained data will be compared between these five groups and it will be tried to determine the optimal method in the pain and anxiety management of the patients. Parameters to be used in the research: * total psa , free psa , hemogram , urea, creatinine, total testosterone. * International prostate symptom score ( IPSS ) and international erectile function index (IIEF- 5) score of 5 questions * Visual analog pain score and state-continuity and anxiety scale scale * Patients' blood pressure, fever, pulse and spo2 values

Interventions

OTHERMusic

A standard music determined by us for the 1st and 4th groups will be played during the process.

DEVICETENS

TENS device will be connected to the 3rd and 5th groups during the process and the process will be done in this way.

Sponsors

Zonguldak Bulent Ecevit University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

Due to the design of the study, it is not possible for patients and specialists to be blinded.

Intervention model description

Patients who applied to the urology outpatient clinic and whose prostate biopsy decision was made according to the criteria specified in the guidelines of the European Urology Society, firstly detailed information about the study will be given after excluding those who were not suitable for the study, and then they will be randomly divided into 5 groups with the help of a computer program.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 50 with high psa * Patients with a family history of psa elevation over the age of 45 * psa \> 10 ng/ml * Patients with abnormal prostate examination * Patients with psa 4-10 who need prostate biopsy * Presence of PIRAD-4 and 5 lesions in multiparametric MR imaging * Patients with consent to participate in the study

Exclusion criteria

* Patients with acute prostatitis * Neutropenic patients * Patients with bleeding diathesis that interferes with the procedure * Patients without consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
pain during procedureduring the procedureVAS (visual analog scale) will be used for pain evaluation. A scale rating from 0 (no pain) to 10 (most painful).

Secondary

MeasureTime frameDescription
anxiety related to procedureduring the procedureSTAI (The State-Trait Anxiety Inventory) will be used for anxiety evaluation. The STAI consists of 40 items, 20 for each subscale. Items are rated on a Likert scale from 1 (not at all/almost never) to 4 (very much so/almost always), and some items are reverse-scored.

Countries

Turkey (Türkiye)

Contacts

Primary ContactReha GİRGİN, Assist.Prof.
mujdereha7477@hotmail.com05378865912
Backup ContactOnur ÖZYAMAN, MD
dr.ozyaman@gmail.com05530119550

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026